BPC
BIIB icon

Banque Pictet & Cie’s Biogen BIIB Stock Holding History

Banque Pictet & Cie’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.1M Sell
65,080
-981
-1% -$188K 0.09% 85
2026
Q1 		$12.1M Sell
66,061
-5,297
-7% -$976K 0.09% 90
2025
Q4 		$12.6M Sell
71,358
-305
-0.4% -$49.8K 0.07% 89
2025
Q3 		$10M Sell
71,663
-362
-0.5% -$48.9K 0.06% 110
2025
Q2 		$9.05M Buy
72,025
+3,751
+5% +$467K 0.06% 110
2025
Q1 		$9.34M Buy
68,274
+4,780
+8% +$683K 0.08% 104
2024
Q4 		$9.71M Buy
63,494
+32,759
+107% +$5.53M 0.06% 104
2024
Q3 		$5.96M Buy
30,735
+966
+3% +$202K 0.05% 138
2024
Q2 		$6.9M Buy
29,769
+1,983
+7% +$431K 0.06% 132
2024
Q1 		$5.99M Buy
27,786
+1,947
+8% +$456K 0.06% 137
2023
Q4 		$6.69M Buy
25,839
+1,817
+8% +$446K 0.06% 134
2023
Q3 		$6.17M Sell
24,022
-15,354
-39% -$4.11M 0.07% 126
2023
Q2 		$11.2M Sell
39,376
-6,058
-13% -$1.8M 0.1% 101
2023
Q1 		$12.6M Sell
45,434
-8,562
-16% -$2.37M 0.12% 89
2022
Q4 		$15M Buy
53,996
+8,821
+20% +$2.49M 0.16% 81
2022
Q3 		$12.1M Buy
45,175
+6,924
+18% +$1.47M 0.13% 90
2022
Q2 		$7.8K Sell
38,251
-21,388
-36% -$4.37M 0.08% 116
2022
Q1 		$12.6M Sell
59,639
-17,442
-23% -$3.79M 0.1% 97
2021
Q4 		$18.5M Buy
77,081
+54,819
+246% +$14.1M 0.14% 84
2021
Q3 		$6.3M Buy
22,262
+7,338
+49% +$2.41M 0.07% 128
2021
Q2 		$5.17M Sell
14,924
-492
-3% -$149K 0.06% 151
2021
Q1 		$4.31M Sell
15,416
-718
-4% -$194K 0.06% 156
2020
Q4 		$3.95M Buy
16,134
+243
+2% +$62.7K 0.05% 155
2020
Q3 		$4.51M Sell
15,891
-275
-2% -$76.7K 0.07% 139
2020
Q2 		$4.33M Sell
16,166
-3,517
-18% -$1.06M 0.07% 144
2020
Q1 		$6.23M Sell
19,683
-4,651
-19% -$1.41M 0.13% 93
2019
Q4 		$7.22M Sell
24,334
-6,694
-22% -$1.86M 0.13% 109
2019
Q3 		$7.22M Sell
31,028
-930
-3% -$217K 0.14% 96
2019
Q2 		$7.47M Buy
31,958
+1,856
+6% +$429K 0.14% 96
2019
Q1 		$7.12M Buy
30,102
+7,392
+33% +$2.33M 0.14% 96
2018
Q4 		$6.83M Buy
22,710
+760
+3% +$243K 0.14% 106
2018
Q3 		$7.75M Buy
21,950
+3
+0% +$1.03K 0.14% 108
2018
Q2 		$6.37M Buy
21,947
+118
+0.5% +$33.2K 0.13% 131
2018
Q1 		$5.98M Hold
21,829
– – 0.13% 131
2017
Q4 		$6.95M Sell
21,829
-91
-0.4% -$29.2K 0.14% 119
2017
Q3 		$6.86M Sell
21,920
-2,020
-8% -$598K 0.16% 117
2017
Q2 		$6.5M Buy
23,940
+2,122
+10% +$561K 0.15% 116
2017
Q1 		$5.96M Buy
21,818
+8,507
+64% +$2.41M 0.15% 113
2016
Q4 		$3.77M Sell
13,311
-218
-2% -$64.6K 0.1% 123
2016
Q3 		$4.24M Buy
13,529
+2,256
+20% +$668K 0.11% 111
2016
Q2 		$2.73M Sell
11,273
-1,805
-14% -$476K 0.07% 156
2016
Q1 		$3.4M Sell
13,078
-1,830
-12% -$483K 0.09% 134
2015
Q4 		$4.57M Sell
14,908
-1,775
-11% -$510K 0.12% 110
2015
Q3 		$4.87M Sell
16,683
-16,450
-50% -$5.43M 0.15% 110
2015
Q2 		$13.4M Buy
33,133
+1,823
+6% +$732K 1.07% 18
2015
Q1 		$13.2M Buy
31,310
+622
+2% +$245K 0.34% 63
2014
Q4 		$10.4M Buy
30,688
+766
+3% +$248K 0.27% 84
2014
Q3 		$9.9M Buy
29,922
+1,560
+6% +$514K 0.26% 72
2014
Q2 		$8.94M Buy
28,362
+37
+0.1% +$11.1K 0.22% 83
2014
Q1 		$8.66M Buy
28,325
+3,623
+15% +$1.15M 0.24% 71
2013
Q4 		$6.91M Buy
+24,702
New +$6.39M 0.2% 85

Other funds holding BIIB

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
ADEF
Adams Diversified Equity Fund Baltimore, Maryland $3.27B AUM 45.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return

Banque Pictet & Cie's BIIB Position: Q2 2026 in Review

Banque Pictet & Cie reduced its Biogen (BIIB) stake by 1.5% in Q2 2026, selling an estimated $188K and leaving 65,080 shares worth $14.1M. The position accounts for 0.09% of the portfolio, ranked #85.

Banque Pictet & Cie first reported a position in BIIB in Q4 2013 and has held it in 51 quarters since. The position peaked at $18.5M in Q4 2021. 269 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Banque Pictet & Cie held 65,080 shares of Biogen worth $14.1M as of Q2 2026.
  • Banque Pictet & Cie sold 981 Biogen shares in Q2 2026, an estimated $188K.
  • Biogen made up 0.09% of Banque Pictet & Cie's portfolio in Q2 2026, its #85 holding.
  • Banque Pictet & Cie first reported a position in Biogen in Q4 2013 and has held it in 51 quarters since.
  • Banque Pictet & Cie's Biogen position peaked at $18.5M in Q4 2021.
  • 269 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Banque Pictet & Cie's 13F filing for Q2 2026, filed 24 Jul 2026.